Some patients tolerate GLP-1 without flares, while others experience symptom exacerbation
Venous stasis dermatitis: Older adults may experience stasis dermatitis from poor circulation
Sarah Neale, Jessica Chertow, Serguei G
Optionally, a controlled-release formulation includes otoprotective agents, such as antioxidants, alpha lipoic acid, calcium, fosfomycin or iron chelators, to counteract potential ototoxic effects that may arise from the use of specific therapeutic agents or excipients, diluents, or carriers
L-Cysteine in vitro can restore cellular glutathione and inhibits the expression of cell adhesion molecules in G6PD-deficient monocytes
Generally, low cardiovascular risk is typically defined as the absence of cardiovascular disease and a Flemingham 10-year risk of cardiovascular events less than 20% ( Conclusion In conclusion, our meta-analysis showed that first-line use of SGLT2i and GLP-1RAs in T2DM patients at low cardiovascular disease risk significantly reduced HbA1c, body weight, and FPG levels in T2DM patients compared with placebo
